Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
What's in Store for These 5 Medical Companies This Earnings Season?
10:11am, Monday, 23'rd Feb 2026
IRWD, RXRX, NVAX, VTRS and NTLA gear up for earnings as the Medical sector posts solid sales growth despite a slight profit dip so far.
Jupiter Asset Management Ltd. Sells 779,802 Shares of Novavax, Inc. $NVAX
05:40am, Monday, 23'rd Feb 2026
Jupiter Asset Management Ltd. trimmed its position in Novavax, Inc. (NASDAQ: NVAX) by 88.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owne
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
08:00am, Thursday, 19'th Feb 2026
GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
10:00am, Tuesday, 17'th Feb 2026
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts
06:45pm, Wednesday, 11'th Feb 2026
Novavax (NVAX) reached $8.97 at the closing of the latest trading day, reflecting a +2.51% change compared to its last close.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 06'th Feb 2026
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Novavax (NVAX) Dipped More Than Broader Market Today
06:46pm, Tuesday, 03'rd Feb 2026
Novavax (NVAX) concluded the recent trading session at $8.37, signifying a -3.68% move from its prior day's close.
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?
10:09am, Friday, 30'th Jan 2026
Moderna, Inc. and Novavax, Inc. have transitioned from pandemic-era highs to focusing on cost reduction, pipeline development, and a path to breakeven by 2028. NVAX leverages partnerships with Sanofi
This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy?
08:30am, Thursday, 29'th Jan 2026
The business may not be as strong as its performance this year suggests.
Here's Why Novavax (NVAX) Fell More Than Broader Market
06:45pm, Wednesday, 28'th Jan 2026
In the latest trading session, Novavax (NVAX) closed at $9.22, marking a -6.07% move from the previous day.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:10am, Monday, 26'th Jan 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
06:45pm, Thursday, 22'nd Jan 2026
In the latest trading session, Novavax (NVAX) closed at $9.71, marking a -1.97% move from the previous day.
Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer
11:11am, Wednesday, 21'st Jan 2026
NVAX inks a non-exclusive Matrix-M license, securing $30M upfront, up to $500M in milestones and mid-single-digit royalties from Pfizer.
Novavax Stock Pops After Pfizer Licensing Agreement
11:12am, Tuesday, 20'th Jan 2026
Novavax Inc. (NASDAQ:NVAX) shares are up 3.3% to trade at $8.27 at last glance, after the vaccine company singed a licensing agreement -- worth up to $500 million, including a $30 million upfront p
Novavax Announces Entering into a License Agreement with Pfizer
07:15am, Tuesday, 20'th Jan 2026
Non-exclusive license allows for development by Pfizer to utilize Matrix-M ® for up to two disease areas with its products Provides Novavax with an upfront payment of $30 million with the potential f
